Skip to main content

Table 2 Endocrine factors of all obese with NAFLD children

From: Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease

Variable rhGH group
(n = 22)
control group
(n = 22)
p value
IGF-1(ng/ml) 223.59 ± 94.82 279.23 ± 128.19 0.109
FT3 (pmmol/L) 6.20 ± 0.63 6.17 ± 0.43 0.816
FT4 (pmmol/L) 16.38 ± 2.31 15.65 ± 2.04 0.273
TSH (μU/mL) 2.77 ± 1.34 2.96 ± 1.05 0.611
ACTH (mmol/L) 24.31 ± 15.33 30.44 ± 13.27 0.163
COR(pg/mL) 355.54 ± 167.14 333.86 ± 136.94 0.640
LH(mIU/ml) 1.84(0.62, 3.34) 0.84(0.62, 2.65) 0.519#
FSH(mIU/ml) 4.29 ± 2.36 3.20 ± 2.04 0.110
Estradiol (pg/ml) 12.98(6.08, 30.85) 13.55(5.79, 24.72) 0.519#
Testosterone (ng/ml) 0.29(0.10, 0.75) 0.30(0.13, 0.95) 0.870#
  1. # p value reported for log transformed values, but values in the table represent as the median (interquartile range)
  2. * p < 0.05
  3. Abbreviations: IGF-1 Insulin-like growth factor 1, FT3 Free Friiodothyronine, FT4 Free thyroxine, TSH Thyroid-stimulating hormone, ACTH Adrenal corticotropic hormone, COR Cortisol, LH Luteinizing hormone, FSH Follicle-stimulating hormone